Press release
Global Osteoporosis Drugs Market to Reach an Estimated Value of US$ 14,786.7 Mn by 2022
The global osteoporosis drugs market is witnessing significant growth due to rising geriatric population and changing lifestyles impinging bone health. Prevalence of osteoporosis is high among people aged 60 years and above. Moreover, increasing the prevalence of osteoporosis in postmenopausal women, growing awareness about osteoporotic care, and increasing investment in drug discovery and development are also driving the growth of the market. However, there are various side effects and complications associated with osteoporosis drugs such as heartburn, irritable bowel syndrome, nausea, and ulcers in the stomach or esophagus. Furthermore, patent expiration of osteoporosis drugs also inhibits the growth of the market.The osteoporosis drugs market is anticipated to grow from an estimated US$11,226.1 Mn by the end of 2015 to account for US$14,786.7 Mn by 2022 at a CAGR of 4.0% during the forecast period.
In North America, the prevalence of osteoporosis is high primarily due to increasing geriatric population, growing obesity, and rising prevalence of lifestyle associated diseases in the region. According to the National Osteoporosis Foundation, in 2013, approximately 54 million people in the U.S. aged 50 years and above were affected by osteoporosis and low bone mass. According to the U.S. Department of Health and Human Services, in the U.S., approximately 250,000 hip fractures are associated with osteoporosis.
In Europe, increasing aging population, changing lifestyles, and increasing consumer awareness about osteoporosis care are driving the growth of the osteoporosis drug market. According to the International Osteoporosis Foundation, approximately 5.5 million men and 22 million women suffered from osteoporosis in 2010. Moreover, according to International Osteoporosis Foundation, approximately 27.5 million people in Europe suffered from osteoporosis in 2010 and the number is expected to reach 33.9 Mn by 2030.
However, the growth of osteoporosis market in Asia Pacific is much due to rising geriatric population and changing lifestyles in the region. Osteoporotic patients have a higher risk of hip fractures, owing to a major cause of morbidity and mortality. According to the International Osteoporosis Foundation, by 2050, approximately 50% of the world’s osteoporosis hip fractures would occur in women in Asia. In addition, according to a study on Epidemiology in Osteoporosis in Japan by the National Centre for Biotechnology Information, in 2011, approximately 15 million people suffered from osteoporosis in Japan.
A Sample of this report is available upon request @ http://www.persistencemarketresearch.com/samples/2983
Eli Lilly and Company, F. Hoffmann-La Roche, Ltd., Merck & Co. Inc., Novartis AG, Amgen, Inc., Actavis plc, Teva Pharmaceuticals Industries Ltd., and Pfizer, Inc. are some of the major players of osteoporosis drugs market.
To Buy Full Report for a Single User @ http://www.persistencemarketresearch.com/checkout/2983
About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.
Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA - Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Osteoporosis Drugs Market to Reach an Estimated Value of US$ 14,786.7 Mn by 2022 here
News-ID: 550905 • Views: …
More Releases from Persistence Market Research
Pediatric Wheelchair Market to Reach to Reach US$ 3.1 Bn by 2031, Growing at 6.3 …
Introduction
The pediatric wheelchair market has witnessed significant growth in recent years due to its essential role in enhancing mobility and independence among children with physical disabilities or mobility impairments. Pediatric wheelchairs are designed specifically for children, offering features such as adjustable seating, lightweight frames, customizable supports, and ergonomic designs that cater to growing bodies. These wheelchairs are widely used in hospitals, rehabilitation centers, schools, and home care settings, ensuring safety,…
Ablation Catheters Market Set to Grow and Garner a Share of US$ 11.7 Billion by …
Introduction
The ablation catheters market has witnessed significant growth in recent years, driven by the rising prevalence of cardiac arrhythmias and the increasing adoption of minimally invasive procedures. Ablation catheters are specialized medical devices used to treat abnormal heart rhythms by delivering energy to targeted cardiac tissue to restore normal electrical conduction. These devices play a critical role in the treatment of conditions such as atrial fibrillation, ventricular tachycardia, and supraventricular…
Endodontic Files Market Expected to Witness Impressive Growth at a 6.7% CAGR by …
Introduction
The endodontic files market has witnessed significant growth in recent years, driven by the increasing prevalence of dental disorders, rising awareness of oral health, and advancements in dental technologies. Endodontic files, essential tools in root canal treatments, are used to clean and shape root canals, ensuring effective treatment and preventing infections. These instruments are widely employed in dental clinics, hospitals, and specialized endodontic centers. Their precision, durability, and compatibility with…
Bone Growth Stimulator Market To Surge Beyond $3.31 Billion By 2031
Introduction
The bone growth stimulator market has witnessed substantial traction in recent years, driven by the rising prevalence of orthopedic conditions, fractures, and spinal disorders. Bone growth stimulators are medical devices designed to promote bone healing and regeneration through electrical, ultrasonic, or electromagnetic stimulation. These devices play a critical role in reducing recovery time, enhancing bone repair, and improving patient outcomes, particularly in cases of non-union fractures, spinal fusion surgeries, and…
More Releases for Osteoporosis
Rising Prevalence Of Osteoporosis Fuels Growth In The Osteoporosis Drug Market: …
The Osteoporosis Drugs Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Osteoporosis Drugs Market Size During the Forecast Period?
The market for medications for osteoporosis has seen a consistent rise in recent years. The current market value of $12.33 billion in 2024…
Rising Prevalence Of Osteoporosis Spurs Momentum In Postmenopausal Osteoporosis …
The Postmenopausal Osteoporosis Treatment Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Current Postmenopausal Osteoporosis Treatment Market Size and Its Estimated Growth Rate?
The market for treatment of postmenopausal osteoporosis has seen a steady increase in size over the recent years. It's projected…
Osteoporosis Drug Market, By Type (Primary Osteoporosis and Secondary Osteoporos …
Osteoporosis is a condition of bone weakening or bones becomes fragile and likely to break. In other words, osteoporosis is a condition wherein the bone density decreases. This is specially witnessed in old age people. Osteoporosis brings along back pain, stooped posture, bone fracture and tooth loss.
View Detailed Report" https://www.databridgemarketresearch.com/reports/global-osteoporosis-drug-market
The global osteoporosis drug market is experiencing steady growth driven by factors such as the increasing aging population, rising prevalence of…
Osteoporosis Drugs: The Complete Review
Medication for osteoporosis increases bone mineral density and reduces fracture risk. Some osteoporosis medications promote bone growth while others reduce bone loss.
The bones may begin to deteriorate as age more quickly than the body can heal them. The doctor could determine that people have osteoporosis if they have significant bone density loss.
To receive free sample pages of this report@ https://www.psmarketresearch.com/market-analysis/osteoporosis-drugs-market/report-sample
Although osteoporosis cannot be treated, it can be slowed down or…
Osteoporosis Drugs Market: Demand for Osteoporosis Drugs High Among Geriatric Po …
The global osteoporosis drugs market is analyzed in a report by Transparency Market Research (TMR). The market is expected to grow due to the increasing geriatric population across the globe. The market for osteoporosis drugs is considered semi-consolidated as a handful of players hold a larger share in the market. As per the analysis, Novartis International AG, Eli Lilly and Company, Merck & Co. Inc., Pfizer Inc., and Amgen Inc.…
Global Postmenopausal Osteoporosis Therapeutics Market
The Postmenopausal Osteoporosis Therapeutics Market report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
Osteoporosis is an orthopedic condition where the bone density and bone mass decreases and eventually increases the risk of bone fracture. Osteoporosis is one of the most common age related…
